Ignite Creation Date:
2025-12-24 @ 7:57 PM
Ignite Modification Date:
2025-12-31 @ 1:26 AM
Study NCT ID:
NCT01439204
Status:
COMPLETED
Last Update Posted:
2014-03-19
First Post:
2011-09-21
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Pharmacokinetic Study to Compare the Blood Levels of Abatacept Manufactured at Lonza Biologics to the Blood Levels of Abatacept Manufactured at the Devens, Massachusetts (MA) Facility of Bristol-Myers Squibb
Sponsor:
Bristol-Myers Squibb
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2011-10
Start Date Type:
None
Primary Completion Date:
2012-02
Primary Completion Date Type:
ACTUAL
Completion Date:
2012-02
Completion Date Type:
ACTUAL
First Submit Date:
2011-09-21
First Submit QC Date:
None
Study First Post Date:
2011-09-23
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2013-11-04
Results First Submit QC Date:
None
Results First Post Date:
2014-02-04
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2014-02-21
Last Update Post Date:
2014-03-19
Last Update Post Date Type:
ESTIMATED